Ovarian metastasis in a patient with neuroendocrine tumour of the small intestine

Affiliations

¹ Clinical Department of Perinatology and Oncological Gynaecology, Medical University of Silesia, Sosnowiec, Poland. brystomasz@wp.pl.
² Department of Endocrinology and Neuroendocrine Tumours, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland.
³ Clinical Department of Perinatology and Oncological Gynaecology, Medical University of Silesia, Sosnowiec, Poland.

Free article

Tomasz Krzysztof Bryś et al. Endokrynol Pol. 2023.

Free article

. 2023;74(6).

doi: 10.5603/ep.98169.

¹ Clinical Department of Perinatology and Oncological Gynaecology, Medical University of Silesia, Sosnowiec, Poland. brystomasz@wp.pl.
² Department of Endocrinology and Neuroendocrine Tumours, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland.
³ Clinical Department of Perinatology and Oncological Gynaecology, Medical University of Silesia, Sosnowiec, Poland.

Abstract

No required for Clinical Vignette.

Keywords: carcinoid syndrome; ovarian metastatic NET; peptide receptor radionuclide therapy; somatostatin analogue.